monoclonal antibodies Archive — Page 4 of 9

White disposable surgical mask labeled “COVID-19” on a light blue background.
December 24, 2021

Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate

New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death.

By Tom Wilemon
Green-gloved laboratory worker holds two small tubes containing clear liquid over a blurred lab coat.
December 9, 2021

Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

By Bill Snyder
Green-gloved laboratory worker holds two small tubes containing clear liquid over a blurred lab coat.
December 2, 2021

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

By Bill Snyder
VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
November 18, 2021

Seven from VUMC among most highly cited researchers

Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers.

By Bill Snyder
Dark, thin, curved line forming a stylized abstract shape with two loops on a textured blue background.
October 28, 2021

VUMC researchers a step closer to broad ebolavirus protection

By Bill Snyder
Three-dimensional illustration of a coronavirus particle with a textured gray spherical surface, red spike proteins, and smaller yellow surface structures; blurred particles appear in the background.
October 21, 2021

Study explores impact of COVID-19 on children

By Jessica Pasley